Cocoa polyphenols treatment ameliorates visceral obesity by reduction lipogenesis and promoting fatty acid oxidation genes in obese rats through interfering with AMPK pathway

• Main Authors: Ali, Faisal, Ismail, Amin, Mohd Esa, Norhaizan, Chong, Pei Pei
• Format: Article
• Language: English
• Published: Wiley-VCH Verlag GmbH & Co. KGaA 2016
• Online Access: http://psasir.upm.edu.my/id/eprint/59674/1/Cocoa%20polyphenols%20treatment%20ameliorates%20visceral%20obesity%20by%20reduction%20lipogenesis%20and%20promoting%20fatty%20acid%20oxidation%20genes%20in%20obese%20rats%20through%20interfering%20with%20AMPK%20pathway.pdf; http://psasir.upm.edu.my/id/eprint/59674/; http://onlinelibrary.wiley.com/wol1/doi/10.1002/ejlt.201400581/abstract
• Institution: Universiti Putra Malaysia

This study was conducted to investigate the pharmacological activity of cocoa polyphenols (CPs) on visceral obesity markers and the possible mechanisms. In this study, Sprague–Dawley (SD) rats were fed either a low-fat diet (LFD) or a high-fat diet (HFD). After 12 wk of diet intervention, only one group of HFD rats (n = 10/group) were treated at a dose of 600 mg/kg bw/day CPs (HFD + CPs) for 4 wk. The gene and protein expression levels of phosphorylation of AMPK-activated protein kinase α/β (AMPK α/β) were measured using real time-PCR and Western blotting. The mRNA expression of lipogenic key enzymes (Acaca, Fasn, Mcat, and Scd-1), and β-oxidation key enzymes (CPT1, Prkaa1, Acox1) were investigated. In addition, the upstream transcription factors (PPARα, PPARγ, C/EBPα, and SREBP-1c) were also examined. In accordance with these findings, CPs treatment improved visceral adiposity, adipocytes hypertrophy, and liver steatosis. AMP-activated protein kinase α/β (AMPK α/β) phosphorylation in liver and adipose tissue of HFD + CPs-treated rats was activated compared with HFD-fed rats. The expression of lipogensis related-genes was decreased, while expression levels of β-oxidation-related genes were increased compared with HFD-fed rats. Together, these data partially unravel the ameliorative effects of CPs treatment on visceral obesity markers by inhibiting lipogenesis and promoting β-oxidation related-genes through activation of the AMPK pathway.